A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 μg ethinyl estradiol and a reference containing desogestrel and 30 μg ethinyl estradiol-Reference-Cited by-同舟云学术

A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 μg ethinyl estradiol and a reference containing desogestrel and 30 μg ethinyl estradiol

Published:2006-04 Issue:4 Volume:73 Page:336-343
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Kluft Cornelis,Endrikat Jan,Mulder Simone M.,Gerlinger Christoph,Heithecker Renate

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference37 articles.

1. Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone;Huber;Eur J Contracept Reprod Health Care,2000

2. An open-label, multi-centered study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen;Parsey;Contraception,2000

3. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models;Muhn;Contraception,1995

4. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity: a major breakthrough in tomorrow's oral contraception;Foidart;Gynaecol Snapshot,1995

5. The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potential;Fuhrmann;Contraception,1996

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of tissue factor pathway inhibitor in hormone-induced venous thromboembolism;Blood Coagulation & Fibrinolysis;2023-04-13

2. The effect of combined oral contraceptives containing drospirenone and ethinylestradiol on serum levels of amino acids and acylcarnitines;Metabolomics;2021-08-19

3. The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism;Expert Review of Clinical Pharmacology;2021-01-26

4. Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk;Seminars in Thrombosis and Hemostasis;2020-10-20

5. Serum Metabolome Changes in Relation to Prothrombotic State Induced by Combined Oral Contraceptives with Drospirenone and Ethinylestradiol;OMICS: A Journal of Integrative Biology;2020-07-01